chr5-58459799-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006622.4(PLK2):c.161C>T(p.Ala54Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006622.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PLK2 | NM_006622.4 | c.161C>T | p.Ala54Val | missense_variant | 1/14 | ENST00000274289.8 | |
PLK2 | NM_001252226.2 | c.161C>T | p.Ala54Val | missense_variant, splice_region_variant | 1/15 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PLK2 | ENST00000274289.8 | c.161C>T | p.Ala54Val | missense_variant | 1/14 | 1 | NM_006622.4 | P1 | |
PLK2 | ENST00000617412.1 | c.161C>T | p.Ala54Val | missense_variant, splice_region_variant | 1/15 | 5 | |||
PLK2 | ENST00000504196.1 | n.288C>T | non_coding_transcript_exon_variant | 1/2 | 2 | ||||
PLK2 | ENST00000514306.1 | n.61C>T | non_coding_transcript_exon_variant | 1/3 | 2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1456150Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 724740
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 19, 2023 | The c.161C>T (p.A54V) alteration is located in exon 1 (coding exon 1) of the PLK2 gene. This alteration results from a C to T substitution at nucleotide position 161, causing the alanine (A) at amino acid position 54 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.